Philipp Schütt

796 total citations
23 papers, 594 citations indexed

About

Philipp Schütt is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hematology. According to data from OpenAlex, Philipp Schütt has authored 23 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Philipp Schütt's work include Multiple Myeloma Research and Treatments (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Philipp Schütt is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Philipp Schütt collaborates with scholars based in Germany, United States and Switzerland. Philipp Schütt's co-authors include Bertram Opalka, Dieter Brandhorst, Peter R. Ebeling, S. Seeber, Hans Grosse‐Wilde, Vera Rebmann, Mohammad R. Nowrousian, Tassilo Moritz, Ulrike Buttkereit and Michael Flaßhove and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Philipp Schütt

22 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Schütt Germany 13 239 197 180 117 101 23 594
Jack O. Egan United States 12 386 1.6× 521 2.6× 166 0.9× 64 0.5× 169 1.7× 17 944
Manfred Hoenig Germany 16 126 0.5× 609 3.1× 199 1.1× 90 0.8× 144 1.4× 33 924
Alessandra Perin Italy 10 197 0.8× 256 1.3× 51 0.3× 122 1.0× 93 0.9× 19 532
Tong Wu China 14 263 1.1× 253 1.3× 468 2.6× 58 0.5× 96 1.0× 66 853
Sai Ravi Pingali United States 14 212 0.9× 109 0.6× 167 0.9× 42 0.4× 95 0.9× 63 529
Ryosei Nishimura Japan 11 252 1.1× 279 1.4× 170 0.9× 37 0.3× 162 1.6× 37 625
Vladimir Vainstein Israel 15 283 1.2× 105 0.5× 236 1.3× 53 0.5× 226 2.2× 51 723
Kuang‐Yueh Chiang United States 12 122 0.5× 139 0.7× 229 1.3× 37 0.3× 120 1.2× 31 481
SJ Goldman United States 9 166 0.7× 267 1.4× 223 1.2× 101 0.9× 143 1.4× 12 595
Y Morishita Japan 15 188 0.8× 374 1.9× 511 2.8× 43 0.4× 83 0.8× 34 869

Countries citing papers authored by Philipp Schütt

Since Specialization
Citations

This map shows the geographic impact of Philipp Schütt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Schütt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Schütt more than expected).

Fields of papers citing papers by Philipp Schütt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Schütt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Schütt. The network helps show where Philipp Schütt may publish in the future.

Co-authorship network of co-authors of Philipp Schütt

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Schütt. A scholar is included among the top collaborators of Philipp Schütt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Schütt. Philipp Schütt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baulig, Werner, Philipp Schütt, Marija Jović, et al.. (2021). Comparison of the resonance sonorheometry based Quantra® system with rotational thromboelastometry ROTEM® sigma in cardiac surgery – a prospective observational study. BMC Anesthesiology. 21(1). 260–260. 15 indexed citations
2.
Schütt, Philipp, et al.. (2021). Surgical Treatment of Cerebellar Metastases: Survival Benefits, Complications and Timing Issues. Cancers. 13(21). 5263–5263. 5 indexed citations
3.
Bozorgmehr, Farastuk, Johannes Claßen, Marcus Stockinger, et al.. (2021). Thoracic radiotherapy PLUS durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy: Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy—The TRADE-hypo trial.. Journal of Clinical Oncology. 39(15_suppl). TPS8585–TPS8585. 4 indexed citations
4.
5.
Faehling, Martin, Christian Schumann, Petros Christopoulos, et al.. (2020). Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP. SHILAP Revista de lepidopterología. 34. 106556–106556. 3 indexed citations
6.
7.
Schiller, Joan H., Joachim von Pawel, Philipp Schütt, et al.. (2010). Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(12). 1977–1985. 45 indexed citations
8.
Schütt, Philipp, Sebastian Bauer, Georgios Stamatis, et al.. (2010). Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients. Human Immunology. 71(5). 489–495. 60 indexed citations
9.
Mönninghoff, Christoph, Stefan Maderwald, Jens Theysohn, et al.. (2010). Imaging of Brain Metastases of Bronchial Carcinomas with 7 T MRI – Initial Results. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 182(9). 764–772. 24 indexed citations
10.
Schütt, Philipp, Vera Rebmann, Dieter Brandhorst, et al.. (2008). The clinical significance of soluble human leukocyte antitgen class-I, ICTP, and RANKL molecules in multiple myeloma patients. Human Immunology. 69(2). 79–87. 14 indexed citations
11.
Dürig, Jan, Peter R. Ebeling, Florian Grabellus, et al.. (2007). A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease. Cancer Research. 67(18). 8653–8661. 49 indexed citations
12.
Rebmann, Vera, Philipp Schütt, Dieter Brandhorst, et al.. (2007). Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients. Clinical Immunology. 123(1). 114–120. 73 indexed citations
13.
Baulig, Werner, et al.. (2007). Clinical Validation of a Digital Transcutaneous PCO2/SpO2 Ear Sensor in Adult Patients after Cardiac Surgery. Journal of Clinical Monitoring and Computing. 21(5). 303–309. 10 indexed citations
14.
15.
Schütt, Philipp, Dieter Brandhorst, Peter R. Ebeling, et al.. (2006). Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections. Leukemia & lymphoma. 47(8). 1570–1582. 99 indexed citations
16.
Glasmacher, Axel, Oliver A. Cornely, Katjana Orlopp, et al.. (2005). Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients. Journal of Antimicrobial Chemotherapy. 57(1). 127–134. 33 indexed citations
17.
Schütt, Philipp, Peter R. Ebeling, Ulrike Buttkereit, et al.. (2005). Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival. Annals of Hematology. 84(9). 594–600. 24 indexed citations
18.
Schütt, Philipp, et al.. (1980). Sural nerve conduction velocity and refractory period in diabetics without clinical signs of neuropathy.. PubMed. 9. 39–42. 6 indexed citations
19.
Schütt, Philipp, et al.. (1979). [Reversible alterations of peripheral nerve function in thyroid dysfunction (author's transl)].. PubMed. 10(2). 101–5. 2 indexed citations
20.
Lehmann, H., et al.. (1977). Refractory Period of Human Sural Nerve Action Potential Related to Age in Healthy Probands. European Neurology. 15(2). 85–93. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jack O. Egan Breakdown of academic impact, for papers by Manfred Hoenig Breakdown of academic impact, for papers by Alessandra Perin Breakdown of academic impact, for papers by Tong Wu Breakdown of academic impact, for papers by Sai Ravi Pingali Breakdown of academic impact, for papers by Ryosei Nishimura Breakdown of academic impact, for papers by Vladimir Vainstein Breakdown of academic impact, for papers by Kuang‐Yueh Chiang Breakdown of academic impact, for papers by SJ Goldman Breakdown of academic impact, for papers by Y Morishita
Rankless by CCL
2026